UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000056877 |
|---|---|
| Receipt number | R000065013 |
| Scientific Title | Characteristics of Strength Training in Physical Therapy Settings An Analysis of Electromyographic and Energy Metabolic Characteristics During Bodyweight and Weight Training |
| Date of disclosure of the study information | 2025/02/01 |
| Last modified on | 2025/03/28 10:25:53 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Characteristics of Strength Training in Physical Therapy Settings
An Analysis of Electromyographic and Energy Metabolic Characteristics During Bodyweight and Weight Training
Acronym
Characteristics of Strength Training in Physical Therapy Settings
Scientific Title
Characteristics of Strength Training in Physical Therapy Settings
An Analysis of Electromyographic and Energy Metabolic Characteristics During Bodyweight and Weight Training
Scientific Title:Acronym
Characteristics of Strength Training in Physical Therapy Settings
Region
| Japan |
Condition
Condition
healthy adults
Classification by specialty
| Rehabilitation medicine |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
Background and Purpose
Bodyweight strength training is commonly performed in physical therapy settings; however, its effectiveness in promoting muscle strengthening and hypertrophy, as well as its potential benefits as aerobic exercise, remains unclear. Similarly, weight training using external loads or machines has been increasingly incorporated into cardiopulmonary and preventive physical therapy. Despite its growing prevalence, the aerobic benefits of weight training are not well understood, nor is the extent to which it fulfills the goal of muscle strengthening compared to bodyweight training.
This study aims to clarify the characteristics of both bodyweight and weight training by measuring joint angles, muscle activity, oxygen consumption, and lactate production during exercise. These findings will contribute to a better understanding of the specific physiological demands and benefits of each training modality in physical therapy interventions.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
During each strength training session, the following measurements will be conducted:
(1) Joint angle assessment,
(2) Electromyographic (EMG) signal analysis,
(3) Expired gas analysis, and
(4) Blood lactate measurement.
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Self control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Educational,Counseling,Training
Type of intervention
| Other |
Interventions/Control_1
Participants will be randomly assigned to one of four groups [Group 1 to Group], with each group consisting of 10 participants. The allocation will be conducted by gathering four participants at a time and assigning them to the four groups by lottery. Each exercise session will last approximately 30 minutes, with one exercise performed per day. Within each group, different exercises will be conducted on separate days. Blood lactate levels will be measured before and after each session. If no specific issues arise, consecutive-day measurements may be conducted. The total duration of participation will vary depending on the group but is expected to range from approximately 3 to 5 days.
Exercise Groups and Movements
Group 1
1 Push-ups
2 Dips
3 Bench press
4 Chest press
Group 2
1 Pull-ups
2 Lat pulldown
Group 3
1 Squats
2 Leg press
Group 4
1 Lateral raises
2 Upright row
3 Shoulder press
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
The study will include approximately 20 healthy male university students and 20 healthy adult males.
Key exclusion criteria
Individuals with musculoskeletal disorders, cardiovascular diseases, diabetes, or other relevant medical conditions will be excluded from participation.
Target sample size
40
Research contact person
Name of lead principal investigator
| 1st name | Yusuke |
| Middle name | |
| Last name | chigira |
Organization
Takasaki University of Health and Welfare
Division name
Faculty of Health and Medical Sciences
Zip code
3700033
Address
27 Nakaorui-machi, Takasaki City, Gunma, Japan
TEL
0273521291
chigira@takasaki-u.ac.jp
Public contact
Name of contact person
| 1st name | Yusuke |
| Middle name | |
| Last name | Chigira |
Organization
Takasaki University of Health and Welfare
Division name
Faculty of Health and Medical Sciences
Zip code
3700033
Address
27 Nakaorui-machi, Takasaki City, Gunma, Japan
TEL
0273521291
Homepage URL
chigira@takasaki-u.ac.jp
Sponsor or person
Institute
Takasaki University of Health and Welfare
Institute
Department
Personal name
Yusuke Chigira
Funding Source
Organization
Takasaki University of Health and Welfare
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Japan
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Takasaki University of Health and Welfare
Address
27 Nakaorui-machi, Takasaki City, Gunma, Japan
Tel
027-352-1291
kuwabara@takasaki-u.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2025 | Year | 02 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Partially published
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2021 | Year | 08 | Month | 01 | Day |
Date of IRB
| 2021 | Year | 08 | Month | 01 | Day |
Anticipated trial start date
| 2021 | Year | 08 | Month | 01 | Day |
Last follow-up date
| 2025 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
| 2025 | Year | 03 | Month | 31 | Day |
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2025 | Year | 01 | Month | 30 | Day |
Last modified on
| 2025 | Year | 03 | Month | 28 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000065013
